NEW
YORK, June 12, 2023 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders of NovoCure
Limited:
On June 6, 2023, NovoCure issued a
press release announcing "positive results" from the Phase 3 LUNAR
clinical trial evaluating the use of its Tumor Treating Fields
("TTFields") therapy together with standard therapies for the
treatment of non-small cell lung cancer. Despite reporting that
patients receiving TTFields combined with standard therapies
achieved median overall survival ("OS") of 13.2 months, compared to
9.9 months for patients treated only with standard therapies,
analysts noted that the therapy was tested in patients who worsened
following chemotherapy, which is no longer the standard of care in
lung cancer, and that most patients first receive immune checkpoint
inhibitors ("ICIs"). Although the Company stated that there was a
"profound OS benefit" with a subgroup of patients who received
ICIs, only a few patients (66) were treated with ICIs.
On this news, NovoCure's ordinary share price fell $35.51 per share, or 43.04%, to close at
$47.00 per share on June 6, 2023.
Due to the forgoing, The Gross Law Firm is investigating
potential securities fraud claims on behalf of
certain NovoCure investors. If you incurred a loss on your
NVCR investment, please contact us using the link below to discuss
your rights.
https://securitiesclasslaw.com/securities/novocure-loss-submission-form/?wire=4
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law
Firm is committed to ensuring that companies adhere to responsible
business practices and engage in good corporate citizenship. The
firm seeks recovery on behalf of investors who incurred losses when
false and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original
content:https://www.prnewswire.com/news-releases/investigation-alert-the-gross-law-firm-notifies-shareholders-of-novocure-limited-of-an-investigation-and-potential-class-action-lawsuit--nasdaq-nvcr-301848799.html
SOURCE The Gross Law Firm